Beneficial effects of Rifaximin in post‐infectious irritable bowel syndrome mouse model beyond gut microbiota

Publisher: John Wiley & Sons Inc

E-ISSN: 1440-1746|33|2|443-452

ISSN: 0815-9319

Source: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.33, Iss.2, 2018-02, pp. : 443-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract